Soo K C, Davidson T I, Selby P, Westbury G
Ann R Coll Surg Engl. 1985 Jul;67(4):263-5.
To facilitate long-term venous access in patients receiving chemotherapy, a subcutaneous totally implantable system (Port-a-Cath, Phamacia) has been used in 14 patients. The method of implantation and the advantages over conventional central venous catheters are discussed. The expense of the system necessitates careful patient selection.
为便于接受化疗的患者长期进行静脉穿刺，我们对14例患者使用了一种皮下完全植入式系统（Port-a-Cath，法玛西亚公司）。文中讨论了该系统的植入方法以及相对于传统中心静脉导管的优点。该系统的费用需要对患者进行仔细筛选。
